Bristol-Myers Squibb ends in red for seventh straight session

Bristol-Myers Squibb (NYSE:BMY) extended losses for the seventh consecutive session on Wednesday as the stock ended 1.58% lower at $44.20.

Between September 16 and September 23, BMY lost over 3%. On a year-to-date basis, it has declined by nearly 21% compared to a 12.86% rise